GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Orient Bio 002630.KS · KRW

Health Care · KRX · 🇰🇷 South Korea

Compare

1,275

-2.89%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2026

Revenue

₩29.75bn

FY2017FY2026

Net income

−₩4.57bn

FY2017FY2026

Free cash flow

₩546.4m

FY2017FY2026

Shareholders' equity

₩68.54bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₩29.75bn₩29.40bn₩28.01bn₩28.82bn₩26.28bn₩52.02bn₩37.70bn₩30.37bn₩121.21bn₩109.02bn
Research and development₩732.6m₩1.00bn₩1.95bn₩1.80bn₩2.59bn₩2.65bn₩1.41bn₩655.3m₩2.00bn₩1.16bn
Operating income−₩4.13bn−₩3.08bn₩4.45bn₩3.47bn−₩3.78bn₩2.31bn−₩11.52bn−₩9.23bn−₩6.56bn−₩9.29bn
Net income−₩4.57bn−₩13.19bn₩12.87bn−₩12.42bn₩34.20bn−₩15.27bn−₩10.88bn−₩19.51bn−₩13.87bn−₩19.13bn
Diluted earnings per share-38.52-111.29108.55-104.78288.43-128.83-91.78-191.61-141.05-253.80

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₩81.62bn₩84.78bn₩96.99bn₩81.05bn₩104.95bn₩71.52bn₩72.11bn₩84.09bn₩190.03bn₩172.63bn
Cash and short-term investments————₩59.04bn₩11.74bn₩3.15bn₩10.07bn₩37.06bn₩21.03bn
Total liabilities₩13.07bn₩12.94bn₩11.89bn₩9.66bn₩21.76bn₩22.97bn₩20.14bn₩21.44bn₩110.11bn₩74.68bn
Debt————₩7.40bn₩8.11bn₩7.22bn₩8.25bn₩64.15bn₩51.70bn
Shareholders' equity₩68.54bn₩71.85bn₩85.10bn₩71.39bn₩83.19bn₩48.54bn₩51.96bn₩64.79bn₩52.72bn₩70.30bn
Shares outstanding119m119m119m119m119m119m119m102m98m75m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₩2.60bn₩752.3m₩3.76bn₩1.16bn₩2.35bn₩8.74bn−₩3.90bn−₩11.54bn−₩1.97bn−₩5.11bn
Capital spending−₩2.05bn−₩4.79bn−₩925.3m−₩485.6m−₩2.21bn−₩256.2m−₩742.9m−₩16.08bn−₩2.99bn−₩5.28bn
Free cash flow₩546.4m−₩4.04bn₩2.83bn₩674.3m₩140.5m₩8.48bn−₩4.65bn−₩27.62bn−₩4.95bn−₩10.39bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩6.59bn₩6.54bn₩8.60bn₩6.93bn₩7.68bn₩6.33bn₩8.96bn₩6.73bn
Operating income₩5.39bn−₩309.6m−₩1.56bn−₩671.2m−₩1.62bn−₩583.1m−₩1.73bn−₩176.6m
Net income₩4.85bn−₩464.8m−₩1.92bn−₩151.1m−₩2.03bn−₩4.11bn−₩1.30bn−₩1.09bn
Diluted earnings per share40.88-3.92-16.19-1.27-17.14-34.66-11.00-9.21
Cash from operations₩4.00bn₩1.23bn₩1.77bn₩99.0m−₩499.0m−₩10.0m−₩593.0m₩1.63bn
Capital spending−₩94.0m−₩539.0m−₩452.0m−₩110.0m−₩946.0m−₩91.0m−₩1.44bn−₩1.45bn
Free cash flow₩3.90bn₩688.0m₩1.32bn−₩11.0m−₩1.45bn−₩101.0m−₩2.04bn₩180.0m
Total assets₩83.42bn₩81.62bn₩80.37bn₩82.15bn₩83.12bn₩84.78bn₩88.56bn₩90.58bn
Shareholders' equity₩72.27bn₩68.54bn₩67.73bn₩69.62bn₩69.81bn₩71.85bn₩76.56bn₩77.82bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue1.1%-10.6%-11.9%
Net income-28.4%-21.5%4.3%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-12.2%0.6%-0.4%-5.9%
Net margin-30.0%-14.9%0.8%-10.8%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-31.1-21.657.0-23.28.5-37.9-55.1-14.5-36.9-37.7
Price to sales4.89.726.210.011.111.115.99.34.26.6

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 30 Mar 2000.

FY2001FY1999
Paid in the year112.25956.129
  • 100-to-44.54 reverse split · 21 Feb 2020
  • 5-for-1 split · 18 Jul 2003
  • 2-for-1 split · 18 Feb 1999

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.